Portfolio company Vivasure Medical was acquired by Haemonetics for up to 185M euros.
JAN 9, 2026
Vivasure Medical is redefining large-bore vascular closure through innovation in advanced polymer implants and delivery systems, focusing on minimally invasive, polymer-based closure systems for cardiovascular and endovascular interventions
Vivasure Medical is redefining large-bore vascular closure through innovation in advanced polymer implants and delivery systems, focusing on minimally invasive, polymer-based closure systems for cardiovascular and endovascular interventions.